Concepedia

Author

Renée Komorowski

Amgen (United States)ORCID

Also Known As

Komorowski, R., Komorowski, Renee, R KOMOROWSKI, R Komorowski, R. Komorowski, Renee Komorowski, Renée Komorowski

37

Publications

2.6K

Citations

21

H-Index

58

Concepts

All Affiliations

Amgen (United States)Medical College of WisconsinArray BioPharma (United States)
RK

About

Renée Komorowski is an author at Amgen (United States) specializing in medicine, pharmacology, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

16

1.7K

2

Biochemistry

8

8

524

3

Health Sciences

7

7

735

4

Natural Sciences

5

5

181

5

Cell Biology

3

3

476

Renée Komorowski

×

29

Publications

2.6K

Citations

21

H-Index

YearCitations

Enhancement of therapeutic protein in vivo activities through glycoengineering

Steve Elliott, Tony Lorenzini, Sheilah Asher,

Nature Biotechnology

2003

509

Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys

Yumei Xiong, Kenneth W. Walker, Xiaoshan Min,

Science Translational Medicine

2017

226

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie,

Science Translational Medicine

2018

217

Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex

Ian N. Foltz, Sylvia Hu, Chadwick King,

Science Translational Medicine

2012

211

Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue

Murielle M. Véniant, Glenn Sivits, Joan Helmering,

Cell Metabolism

2015

194

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan,

Nature Metabolism

2024

160

Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys

Murielle M. Véniant, Renée Komorowski, Ping Chen,

Endocrinology

2012

149

Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys

Hai Yan, Wei Gu, Jie Yang,

Journal of Pharmacology and Experimental Therapeutics

2009

129

Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia

Wei Gu, Hai Yan, Katherine A. Winters,

Journal of Pharmacology and Experimental Therapeutics

2009

102

Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors

David J. Lloyd, David J. St. Jean, Robert J. Kurzeja,

Nature

2013

96

Page 1